What is a stock summary page? Click here for an overview.
Business Description
Lupin Ltd
ISIN : INE326A01037
Share Class Description:
BOM:500257: Ordinary SharesCompare
Compare
Traded in other countries / regions
500257.India IPO Date
1995-05-02Description
Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.03 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | 0.68 | |||||
Interest Coverage | 16.02 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 7.11 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EBITDA Growth Rate | 13.1 | |||||
3-Year EPS without NRI Growth Rate | 20.9 | |||||
3-Year FCF Growth Rate | 33.3 | |||||
3-Year Book Growth Rate | 1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 24.66 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.03 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.95 | |||||
9-Day RSI | 50.31 | |||||
14-Day RSI | 50.3 | |||||
3-1 Month Momentum % | -3.05 | |||||
6-1 Month Momentum % | -3.98 | |||||
12-1 Month Momentum % | 29.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.22 | |||||
Cash Ratio | 0.44 | |||||
Days Inventory | 250.84 | |||||
Days Sales Outstanding | 80.64 | |||||
Days Payable | 145.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.38 | |||||
Dividend Payout Ratio | 0.13 | |||||
3-Year Dividend Growth Rate | -12.6 | |||||
Forward Dividend Yield % | 0.38 | |||||
5-Year Yield-on-Cost % | 0.3 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 1.52 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.4 | |||||
Operating Margin % | 18.2 | |||||
Net Margin % | 13.33 | |||||
FCF Margin % | 12.63 | |||||
ROE % | 19.93 | |||||
ROA % | 11.8 | |||||
ROIC % | 17.52 | |||||
3-Year ROIIC % | 187.78 | |||||
ROC (Joel Greenblatt) % | 36.2 | |||||
ROCE % | 24.38 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.61 | |||||
Forward PE Ratio | 22.7 | |||||
PE Ratio without NRI | 31.61 | |||||
Shiller PE Ratio | 63.74 | |||||
Price-to-Owner-Earnings | 40.18 | |||||
PS Ratio | 4.21 | |||||
PB Ratio | 5.78 | |||||
Price-to-Tangible-Book | 8.08 | |||||
Price-to-Free-Cash-Flow | 33.3 | |||||
Price-to-Operating-Cash-Flow | 24.83 | |||||
EV-to-EBIT | 23.87 | |||||
EV-to-Forward-EBIT | 21.09 | |||||
EV-to-EBITDA | 18.09 | |||||
EV-to-Forward-EBITDA | 15.42 | |||||
EV-to-Revenue | 4.28 | |||||
EV-to-Forward-Revenue | 2.99 | |||||
EV-to-FCF | 32.51 | |||||
Price-to-GF-Value | 1.42 | |||||
Price-to-Projected-FCF | 4.92 | |||||
Price-to-Median-PS-Value | 1.53 | |||||
Price-to-Graham-Number | 3.55 | |||||
Price-to-Net-Current-Asset-Value | 17.78 | |||||
Earnings Yield (Greenblatt) % | 4.19 | |||||
FCF Yield % | 2.95 | |||||
Forward Rate of Return (Yacktman) % | -21.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lupin Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 215,250.2 | ||
EPS (TTM) (₹) | 62.7 | ||
Beta | 0.91 | ||
3-Year Sharpe Ratio | 1.05 | ||
3-Year Sortino Ratio | 1.9 | ||
Volatility % | 34.23 | ||
14-Day RSI | 50.3 | ||
14-Day ATR (₹) | 79.280461 | ||
20-Day SMA (₹) | 2007.6475 | ||
12-1 Month Momentum % | 29.71 | ||
52-Week Range (₹) | 1493.75 - 2403.45 | ||
Shares Outstanding (Mil) | 456.57 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lupin Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lupin Ltd Stock Events
Event | Date | Price (₹) | ||
---|---|---|---|---|
No Event Data |
Lupin Ltd Frequently Asked Questions
What is Lupin Ltd(BOM:500257)'s stock price today?
The current price of BOM:500257 is ₹2019.10. The 52 week high of BOM:500257 is ₹2403.45 and 52 week low is ₹1493.75.
When is next earnings date of Lupin Ltd(BOM:500257)?
The next earnings date of Lupin Ltd(BOM:500257) is 2025-05-06 Est..
Does Lupin Ltd(BOM:500257) pay dividends? If so, how much?
The Dividend Yield %  of Lupin Ltd(BOM:500257) is 0.38% (As of Today), Highest Dividend Payout Ratio of Lupin Ltd(BOM:500257) was 4.6. The lowest was 0.06. And the median was 0.24. The  Forward Dividend Yield % of Lupin Ltd(BOM:500257) is 0.38%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |